These final results, together with a prior report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 support the principle of targeting ACKR3 as a singular solution to modulate the opioid process, which could open up new therapeutic avenues for opioid-similar Ailments. It may also be https://brettn369tpk8.wikifrontier.com/user